Interleukin-2 in CD8+ T cells correlates with Banff score during organ rejection in liver transplant recipients

Clinical and Experimental Medicine

Volumn 9, Issue 4, 2009, Pages 259-262

  Akoglu, Bora ^b   Kriener, Susanne ^a   Martens, Swantje ^a   Herrmann, Eva ^a   Hofmann, Wolf Peter ^a   Milovic, Vladan ^c   Zeuzem, Stefan ^a   Faust, Dominik ^b  

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^b Asklepios Medical Center   (Germany)

^c MediClin Deister Weser Kliniken   (Germany)

Author keywords

Banff score; Flow cytometry; Interleukin 2; Liver transplantation; Rejection

Indexed keywords

CD3 ANTIGEN; CD8 ANTIGEN; INTERLEUKIN 2;

ACUTE GRAFT REJECTION; ADULT; AGED; ARTICLE; BANFF SCORE; CD8+ T LYMPHOCYTE; CELL LEVEL; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOTOXIC T LYMPHOCYTE; DIAGNOSTIC TEST; EARLY DIAGNOSIS; FEMALE; FLOW CYTOMETRY; GRAFT RECIPIENT; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; LIVER BIOPSY; LIVER GRAFT REJECTION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY;

ACUTE DISEASE; CASE-CONTROL STUDIES; CD8-POSITIVE T-LYMPHOCYTES; FEMALE; FLOW CYTOMETRY; GRAFT REJECTION; HUMANS; INTERLEUKIN-2; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY;

EID: 70349918127     PISSN: 15918890     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10238-009-0042-4     Document Type: Article

References (18)

1. F Conti B Dousset D Archambeau A Louvel D Houssin Y Calmus 1995 Enhanced risk of steroid-resistant acute rejection following pretransplant steroid therapy in liver graft recipients Transplantation 60 1104 1108 7482716 10.1097/00007890-199511270-00008 1:CAS:528:DyaK28XotVSjtQ%3D%3D
2. R Hirose JP Roberts D Quan, et al. 2000 Experience with daclizumab in liver transplantation: renal transplant dosing without calcineurin inhibitors is insufficient to prevent acute rejection in liver transplantation Transplantation 69 307 311 10670644 10.1097/00007890-200001270-00019 1:CAS:528:DC%2BD3cXhtV2ku7k%3D
3. H Andreu A Rimola M Bruguera, et al. 2002 Acute cellular rejection in liver transplant recipients under cyclosporine immunosuppression: predictive factors of response to antirejection therapy Transplantation 73 1936 1943 12131692 10.1097/00007890-200206270-00016
4. M Hojo T Morimoto M Maluccio, et al. 1999 Cyclosporine induces cancer progression by a cell-autonomous mechanism Nature 397 530 534 10028970 10.1038/17401 1:CAS:528:DyaK1MXhtlCkur0%3D (Pubitemid 29093252)
5. E van Twuyver J de Hoop RJ ten Berge, et al. 1996 Comparison of T cell responses in patients with a long-term surviving renal allograft versus a long-term surviving liver allograft it's a different world Transplantation 61 1392 1397 8629303 10.1097/00007890-199605150-00019 (Pubitemid 26152831)
6. M Koch G Niemeyer I Patel S Light B Nashan 2002 Pharmacokinetics, pharmacodynamics, and immunodynamics of daclizumab in a two-dose regimen in liver transplantation Transplantation 73 1640 1646 12042653 10.1097/00007890- 200205270-00020 1:CAS:528:DC%2BD38XkvFGmur0%3D (Pubitemid 34568679)
7. G Niemeyer M Koch S Light ER Kuse B Nashan 2002 Long-term safety, tolerability and efficacy of daclizumab (Zenapax) in a two-dose regimen in liver transplant recipients Am J Transplant 2 454 460 12123212 10.1034/j.1600-6143. 2002.20510.x 1:CAS:528:DC%2BD38Xltlaqtr8%3D (Pubitemid 36306887)
8. T Nikaido A Shimizu N Ishida, et al. 1984 Molecular cloning of cDNA encoding human interleukin-2 receptor Nature 311 631 635 6090949 10.1038/311631a0 1:CAS:528:DyaL2MXhvVyntg%3D%3D (Pubitemid 14000654)
9. J Liu JD Farmer Jr WS Lane J Friedman I Weissman SL Schreiber 1991 Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes Cell 66 807 815 1715244 10.1016/0092-8674(91)90124-H 1:CAS:528:DyaK3MXlsV2qu7w%3D
10. S Ho N Clipstone L Timmermann, et al. 1996 The mechanism of action of cyclosporin A and FK506 Clin Immunol Immunopathol 80 S40 S45 8811062 10.1006/clin.1996.0140 1:CAS:528:DyaK28XlvFKqsL0%3D (Pubitemid 26317357)
11. TD Batiuk F Pazderka PF Halloran 1995 Calcineurin activity is only partially inhibited in leukocytes of cyclosporine-treated patients Transplantation 59 1400 1404 7770925 10.1097/00007890-199505270-00007 1:STN:280:DyaK2M3ovVOqtg%3D%3D
12. KP Platz AR Mueller R Rossaint, et al. 1996 Cytokine pattern during rejection and infection after liver transplantation-improvements in postoperative monitoring? Transplantation 62 50 1441 10.1097/00007890-199611270- 00011
13. Banff schema for grading liver allograft rejection: An international consensus document (1997) Hepatology 25:658-663
14. JG O'Grady A Burroughs P Hardy D Elbourne A Truesdale 2002 Tacrolimus versus microemulsified ciclosporin in liver transplantation: the TMC randomised controlled trial Lancet 360 1119 1125 12387959 10.1016/S0140-6736(02)11196-2
15. E Boleslawski F Conti S Sanquer, et al. 2004 Defective inhibition of peripheral CD8+ T cell IL-2 production by anti-calcineurin drugs during acute liver allograft rejection Transplantation 77 1815 1820 15223897 10.1097/01.TP.0000129914.75547.B3 1:CAS:528:DC%2BD2cXlt1WmtLk%3D (Pubitemid 38822202)
16. FV Veronese RC Manfro FR Roman, et al. 2005 Reproducibility of the Banff classification in subclinical kidney transplant rejection Clin Transplant 19 518 521 16008598 10.1111/j.1399-0012.2005.00377.x (Pubitemid 40990663)
17. BJ Nankivell JR Chapman 2006 The significance of subclinical rejection and the value of protocol biopsies Am J Transplant 6 2006 2012 16796717 10.1111/j.1600-6143.2006.01436.x 1:STN:280:DC%2BD28rgs1Wnsw%3D%3D (Pubitemid 44199535)
18. MJ Dallman O Shiho TH Page KJ Wood PJ Morris 1991 Peripheral tolerance to alloantigen results from altered regulation of the interleukin 2 pathway J Exp Med 173 79 87 1985127 10.1084/jem.173.1.79 1:CAS:528:DyaK3MXnvFynuw%3D%3D